GEHC (GE HealthCare Technologies Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by GEHC officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-04 | Philip Rackliffe | CEO, AIS | F | — | — |
| 2026-09-04 | Taha Kass-Hout | Chief Technology Officer | F | — | — |
| 2026-09-04 | Catherine Estrampes | Chief Commer. & Growth Officer | F | — | — |
| 2026-09-04 | Adam Y Holton | Chief People Officer | F | — | — |
| 2026-09-04 | Peter J Arduini | President and CEO | F | — | — |
| 2026-09-04 | George A. Newcomb | Chief Accounting Officer | F | — | — |
| 2026-09-04 | Frank R Jimenez | GC & Corporate Secretary | F | — | — |
| 2026-09-04 | Kevin Michael O'Neill | CEO, PDx | F | — | — |
| 2026-09-03 | Adam Y Holton | Chief People Officer | F | — | — |
| 2026-09-03 | Philip Rackliffe | CEO, AIS | F | — | — |
| 2026-09-03 | Jeannette Bankes | CEO, Patient Care Solutions | F | — | — |
| 2026-09-03 | Taha Kass-Hout | Chief Technology Officer | F | — | — |
| 2026-09-03 | Frank R Jimenez | GC & Corporate Secretary | F | — | — |
| 2026-09-03 | Peter J Arduini | President and CEO | F | — | — |
| 2026-08-18 | Adam Y Holton | Chief People Officer | F | — | — |
| 2026-05-26 | Kevin Lobo | Director | Buy | — | — |
| 2026-05-19 | Jeannette Bankes | CEO, Patient Care Solutions | F | — | — |
| 2026-05-19 | Philip Rackliffe | CEO, AIS | A | — | — |
| 2026-05-13 | Rodney F Hochman | Director | Buy | — | — |
| 2026-05-11 | William J Stromberg | Director | A | — | — |
| 2026-05-11 | Anne T Madden | Director | A | — | — |
| 2026-05-11 | Kevin Lobo | Director | A | — | — |
| 2026-05-11 | CATHERINE A LESJAK | Director | A | — | — |
| 2026-05-11 | Rodney F Hochman | Director | A | — | — |
| 2026-05-11 | H LAWRENCE CULP JR | Director | A | — | — |
| 2026-05-11 | Watkin Phoebe L. Yang | Director | MIXED | — | — |
| 2026-05-07 | William J Stromberg | Director | Buy | — | — |
| 2026-05-07 | H LAWRENCE CULP JR | Director | Buy | — | — |
| 2026-05-01 | JAMES SACCARO | Chief Financial Officer | Buy | — | — |
| 2026-04-30 | Peter J Arduini | President and CEO | Buy | — | — |
| 2026-04-30 | Frank R Jimenez | GC & Corporate Secretary | Buy | — | — |
| 2026-03-17 | Kevin Lobo | Director | A | — | — |
| 2026-03-04 | Peter J Arduini | President and CEO | A | — | — |
| 2026-03-04 | JAMES SACCARO | Chief Financial Officer | A | — | — |
| 2026-03-04 | Roland Rott | CEO, Imaging | A | — | — |
| 2026-03-04 | Philip Rackliffe | CEO, AVS | A | — | — |
| 2026-03-04 | Kevin Michael O'Neill | CEO, PDx | A | — | — |
| 2026-03-04 | George A. Newcomb | Chief Accounting Officer | A | — | — |
| 2026-03-04 | Adam Y Holton | Chief People Officer | A | — | — |
| 2026-03-04 | Taha Kass-Hout | Chief Technology Officer | A | — | — |
| 2026-03-04 | Frank R Jimenez | GC & Corporate Secretary | A | — | — |
| 2026-03-04 | Jeannette Bankes | CEO, Patient Care Solutions | A | — | — |
| 2026-02-17 | Peter J Arduini | President and CEO | MIXED | — | — |
| 2026-02-17 | JAMES SACCARO | Chief Financial Officer | MIXED | — | — |
| 2026-02-17 | Frank R Jimenez | GC & Corporate Secretary | MIXED | — | — |
| 2026-02-17 | Taha Kass-Hout | Chief Technology Officer | MIXED | — | — |
| 2026-02-17 | Roland Rott | CEO, Imaging | MIXED | — | — |
| 2026-02-17 | Philip Rackliffe | CEO, AVS | MIXED | — | — |
| 2026-02-17 | Kevin Michael O'Neill | CEO, PDx | MIXED | — | — |
| 2026-02-17 | George A. Newcomb | Chief Accounting Officer | MIXED | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 32,631,302 | — |
| — | Director | 344,553 | — |
| — | President and CEO | 241,606 | — |
| — | GC & Corporate Secretary | 89,321 | — |
| — | Chief Technology Officer | 88,467 | — |
| — | Chief Financial Officer | 87,471 | — |
| — | Chief Financial Officer | 66,887 | — |
| — | CEO, Imaging | 63,348 | — |
| — | Chief People Officer | 54,459 | — |
| — | CEO, AIS | 41,533 | — |
| — | CEO, Imaging | 41,082 | — |
| — | Chief Enterprise Oper. Officer | 40,996 | — |
| — | CEO, Patient Care Solutions | 37,293 | — |
| — | CEO, PDx | 32,085 | — |
| — | Chief Commer. & Growth Officer | 23,573 | — |
| — | Director | 21,504 | — |
| — | Chief People Officer | 19,533 | — |
| — | Director | 19,479 | — |
| — | Director | 18,916 | — |
| — | CEO, Patient Care Solutions | 18,501 | — |
| — | Director | 14,363 | — |
| — | Director | 13,702 | — |
| — | Director | 12,702 | — |
| — | Chief Accounting Officer | 10,527 | — |
| — | Director | 10,157 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the GEHC quote page; the site-wide leaderboard is on the insider transactions hub.